Clinical Trials Directory

Trials / Completed

CompletedNCT01272076

Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)

Status
Completed
Phase
Study type
Observational
Enrollment
85 (actual)
Sponsor
Carl Zeiss Meditec, Inc. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to compare Cirrus HD-OCT automated measurements of the illumination area under the retinal pigment epithelium (RPE) to expert manual measurements of areas of hypofluorescence typical of geographic atrophy in fundus autofluorescence (FAF) images.

Detailed description

Specific Objectives: 1. To compare Cirrus HD-OCT automated measurements of the illumination area under the RPE to expert manual measurements of areas of hypofluorescence typical of geographic atrophy in fundus autofluorescence (FAF) images. 2. To describe the differences and similarities between Cirrus HD-OCT and fundus autofluorescence images of subjects with geographic atrophy secondary to dry age-related macular degeneration (AMD). 3. To determine the clinical factors that affect the Cirrus HD-OCT automated measurements of the illumination area under the RPE.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2011-01-07
Last updated
2014-01-20
Results posted
2013-11-14

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01272076. Inclusion in this directory is not an endorsement.